user avatar
Gil Morgan, MD
@weoncologists
Clinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏
San Antonio, TX
Joined May 2009
Posts
  • Pinned
    user avatar
    A pleasure to publish this at @CD_AACR w/some AMAZING @OncoAlert 🚨colleagues/friends SoMe has immense potential in ALL areas of medicine⚕️ ☑️raises awareness on trials ☑️promotes cancer prevention ☑️amplifies oncology info ☑️enables diverse viewpoints aacrjournals.org/cancerdiscover…
  • user avatar
    Career Opportunities for #YoungOncologists @myESMO free to download @ESMO_Open &Great tools for young #ESMO members esmoopen.bmj.com/content/1/6/e0…
  • user avatar
    A @ChinaEasternweb ✈️Airbus A350 from #Shanghai landed in #Rome carrying 9️⃣ doctors👩‍⚕️👨‍⚕️with expertisen in #Covid19 & 3️⃣1️⃣Tons worth of supplies🇨🇳🙌 1000 #ventilators 100.000 #masks 20.000 #protectivegear 50.000 #testkits One World 🌎 One Love❤️
  • user avatar
    in memory of Dr. Laura Silinskyte November 1984-May 2021 RIP @ESICM member @LSMUNI Alumni Victim of Medical #bullying Victim of #Suicide @LithuaniaHealth @EUPHActs @EU_Commission #StandUpToBullying links to Lithuanian news bit.ly/3ybZDHY bit.ly/3w8Br7n
    00:00
  • user avatar
    Just Out @NEJM #ASCO22 Randomized Trial of4⃣5⃣5⃣patients sees that; ✅A ctDNA-guided approach to the tx of stage II #ColonCancer reduced📉adj chemo use without compromising recurrence-free survival‼️ @OncoAlert 🚨 nejm.org/doi/full/10.10…
  • user avatar
    Hi @TwitterSupport the account for @OncoAlert 🚨has been locked because we updated the birthday to reflect the start of the network March 25, 2019 In doing so our @TwitterBlue verified account was locked out due to AGE restrictions We're an Oncology⚕️Network ⚠️PLEASE RETWEET‼️
  • user avatar
    The 4⃣th @NEJM from #ASCO22 DESTINY Breast04 Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced #BreastCancer ✅trastuzumab deruxtecan resulted in significantly longer PFS &OS🆚Chemo🧪 ✅OS 23.9 mo🆚17.5 mo ✅PFS 10.1🆚5.4 mo @OncoAlert 🚨 nejm.org/doi/full/10.10…
  • user avatar
    Just Out at @NEJM by our @OncoAlert 🚨colleagues @JavierCortesMD @hoperugo @LoiSher & team KEYNOTE355 🔑 See in patients w/adv triple-negative #BreastCancer w PD-L1 expression ✅ addition of pembro to chemo resulted in longer OS 🆚 Chemo Alone nejm.org/doi/full/10.10…
  • user avatar
    Just Presented at #ASCO22 🌐 Just Published in @JCO_ASCO Prospective study of 1⃣0⃣3⃣ patients w/high-risk HR+ #BreastCancer in late adjuvant setting; ✅ctDNA 🧬was identified a median of1⃣year before ALL cases of distant metastasis‼️ @OncoAlert 🚨 ascopubs.org/doi/10.1200/JC…
  • user avatar
    I know it’s not the @OncoAlert 🚨#laughteristhebestmedicine Friday .....but it was just too good. SO FEEL LIKE THIS !!
  • user avatar
    Things are happening in #SanFrancisco for @ASCO #GU19! So far in 3 days, 3 @NEJM papers, great job to all those involved!
  • user avatar
    Dear colleagues, Please join me in welcoming our new @myESMO President, our amazing friend & colleague @peters_solange Our heartfelt thanks to president @TaberneroJosep for his leadership & vision, both indeed a great inspiration for many of us in our society. Sincerely, Gil
  • user avatar
    Sometimes it’s better not to explain🙈🙉🙊.....laughter is indeed the best medicine, happy weekend my friends‼️
  • user avatar
    Just out at @NEJM patients w resectable, early-stage #NSCLC 🫁neoadj pembro🧪plus chemo followed by resection and adjuvant pembro significantly improved event-free survival, major pathological response, and pathological complete response‼️ nejm.org/doi/full/10.10…